Healthcare Journal Guam: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal Guam.

Press releases published on October 26, 2026

8 hours ago

NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries

Indeterminate GlobeNewswire

8 hours ago

Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Indeterminate GlobeNewswire

8 hours ago

Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine

Indeterminate GlobeNewswire

8 hours ago

X9 Receives FDA Breakthrough Device Designation for Investigational Dialysis Cannulation System and Completes Second Clinical Study

Indeterminate GlobeNewswire

8 hours ago

SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies

Indeterminate GlobeNewswire

8 hours ago

Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management

Indeterminate GlobeNewswire

8 hours ago

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire

8 hours ago

Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market

Indeterminate GlobeNewswire

8 hours ago

More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds

Indeterminate GlobeNewswire

8 hours ago

Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

Indeterminate GlobeNewswire

8 hours ago

Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease

Indeterminate GlobeNewswire

9 hours ago

Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback

Indeterminate GlobeNewswire

9 hours ago

Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly

Indeterminate GlobeNewswire

9 hours ago

Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability

Indeterminate GlobeNewswire

9 hours ago

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

9 hours ago

CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

9 hours ago

SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences

Indeterminate GlobeNewswire

9 hours ago

Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire

9 hours ago

Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504

Indeterminate GlobeNewswire

9 hours ago

Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas

Indeterminate GlobeNewswire